In pharmaceutical manufacturing, fill-finish operations are critical, since fill-finish is the last step before a product is packaged and ultimately delivered to the patient. By the time a drug reaches this stage, the drug product is highly valuable, as it has already been through labor- and cost-intensive production stages, including upstream processing, cell culture or fermentation and downstream purification. Failures in the integrity of the fill-finish stage can introduce microbial contamination and generate issues with formulation and dosing
The global Biologics Fill-Finish Services market is projected to reach US$ 2742 million in 2029, increasing from US$ 1825 million in 2022, with the CAGR of 6.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biologics Fill-Finish Services market research.
The Biologics Fill-Finish Services market has grown due to the demand for specialized expertise in the final stages of biopharmaceutical production. These services involve filling and packaging biologic drug products into vials, syringes, or other containers, ensuring sterility and stability. Biologics, such as monoclonal antibodies and vaccines, require stringent handling to maintain their efficacy. Outsourcing fill-finish operations to specialized contract manufacturing organizations (CMOs) is common, as it allows pharmaceutical companies to focus on research and development. The market's expansion reflects the increasing complexity of biologics and the need for efficient, compliant, and high-quality fill-finish processes to bring safe and effective biologic products to market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biologics Fill-Finish Services market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing
Ajinomoto Bio-Pharma Services
CMIC CMO
GRAM (Grand River Aseptic Manufacturing)
TAIYO Pharma Tech Co.,Ltd.
HALIX
Cognate BioServices
Afton Scientific
Novasep
Emergent BioSolutions
Seikagaku
Jiangshu YAOHAI Bio-pharmaceutical
Akron Biotech
Symbiosis Pharmaceutical Services
Techdow
Vigene Biosciences
Segment by Type
Ampoule Filling Services
Vial Filling Services
Prefilled Syringes Filling Services
Others
Segment by Application
Vaccines
Biologics and Biosimilar
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biologics Fill-Finish Services report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. 麻豆原创 Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: 麻豆原创 Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Biologics Fill-Finish Services 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Ampoule Filling Services
1.2.3 Vial Filling Services
1.2.4 Prefilled Syringes Filling Services
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Biologics Fill-Finish Services 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Vaccines
1.3.3 Biologics and Biosimilar
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Fill-Finish Services 麻豆原创 Perspective (2018-2029)
2.2 Biologics Fill-Finish Services Growth Trends by Region
2.2.1 Global Biologics Fill-Finish Services 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biologics Fill-Finish Services Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Biologics Fill-Finish Services Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Biologics Fill-Finish Services 麻豆原创 Dynamics
2.3.1 Biologics Fill-Finish Services Industry Trends
2.3.2 Biologics Fill-Finish Services 麻豆原创 Drivers
2.3.3 Biologics Fill-Finish Services 麻豆原创 Challenges
2.3.4 Biologics Fill-Finish Services 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Fill-Finish Services Players by Revenue
3.1.1 Global Top Biologics Fill-Finish Services Players by Revenue (2018-2023)
3.1.2 Global Biologics Fill-Finish Services Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Biologics Fill-Finish Services 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologics Fill-Finish Services Revenue
3.4 Global Biologics Fill-Finish Services 麻豆原创 Concentration Ratio
3.4.1 Global Biologics Fill-Finish Services 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Fill-Finish Services Revenue in 2022
3.5 Biologics Fill-Finish Services Key Players Head office and Area Served
3.6 Key Players Biologics Fill-Finish Services Product Solution and Service
3.7 Date of Enter into Biologics Fill-Finish Services 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Fill-Finish Services Breakdown Data by Type
4.1 Global Biologics Fill-Finish Services Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Biologics Fill-Finish Services Forecasted 麻豆原创 Size by Type (2024-2029)
5 Biologics Fill-Finish Services Breakdown Data by Application
5.1 Global Biologics Fill-Finish Services Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Biologics Fill-Finish Services Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Biologics Fill-Finish Services 麻豆原创 Size (2018-2029)
6.2 North America Biologics Fill-Finish Services 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biologics Fill-Finish Services 麻豆原创 Size by Country (2018-2023)
6.4 North America Biologics Fill-Finish Services 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics Fill-Finish Services 麻豆原创 Size (2018-2029)
7.2 Europe Biologics Fill-Finish Services 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biologics Fill-Finish Services 麻豆原创 Size by Country (2018-2023)
7.4 Europe Biologics Fill-Finish Services 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Fill-Finish Services 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Biologics Fill-Finish Services 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biologics Fill-Finish Services 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Biologics Fill-Finish Services 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics Fill-Finish Services 麻豆原创 Size (2018-2029)
9.2 Latin America Biologics Fill-Finish Services 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biologics Fill-Finish Services 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Biologics Fill-Finish Services 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Fill-Finish Services 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Biologics Fill-Finish Services 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biologics Fill-Finish Services 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Biologics Fill-Finish Services 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter BioPharma Solutions
11.1.1 Baxter BioPharma Solutions Company Detail
11.1.2 Baxter BioPharma Solutions Business Overview
11.1.3 Baxter BioPharma Solutions Biologics Fill-Finish Services Introduction
11.1.4 Baxter BioPharma Solutions Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.1.5 Baxter BioPharma Solutions Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Biologics Fill-Finish Services Introduction
11.2.4 Boehringer Ingelheim Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Vetter Pharma
11.3.1 Vetter Pharma Company Detail
11.3.2 Vetter Pharma Business Overview
11.3.3 Vetter Pharma Biologics Fill-Finish Services Introduction
11.3.4 Vetter Pharma Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.3.5 Vetter Pharma Recent Development
11.4 Fresenius Kabi
11.4.1 Fresenius Kabi Company Detail
11.4.2 Fresenius Kabi Business Overview
11.4.3 Fresenius Kabi Biologics Fill-Finish Services Introduction
11.4.4 Fresenius Kabi Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.4.5 Fresenius Kabi Recent Development
11.5 Pfizer CentreOne
11.5.1 Pfizer CentreOne Company Detail
11.5.2 Pfizer CentreOne Business Overview
11.5.3 Pfizer CentreOne Biologics Fill-Finish Services Introduction
11.5.4 Pfizer CentreOne Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.5.5 Pfizer CentreOne Recent Development
11.6 Aenova
11.6.1 Aenova Company Detail
11.6.2 Aenova Business Overview
11.6.3 Aenova Biologics Fill-Finish Services Introduction
11.6.4 Aenova Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.6.5 Aenova Recent Development
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Detail
11.7.2 WuXi Biologics Business Overview
11.7.3 WuXi Biologics Biologics Fill-Finish Services Introduction
11.7.4 WuXi Biologics Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.7.5 WuXi Biologics Recent Development
11.8 Jubilant HollisterStier
11.8.1 Jubilant HollisterStier Company Detail
11.8.2 Jubilant HollisterStier Business Overview
11.8.3 Jubilant HollisterStier Biologics Fill-Finish Services Introduction
11.8.4 Jubilant HollisterStier Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.8.5 Jubilant HollisterStier Recent Development
11.9 Bushu Pharmaceuticals
11.9.1 Bushu Pharmaceuticals Company Detail
11.9.2 Bushu Pharmaceuticals Business Overview
11.9.3 Bushu Pharmaceuticals Biologics Fill-Finish Services Introduction
11.9.4 Bushu Pharmaceuticals Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.9.5 Bushu Pharmaceuticals Recent Development
11.10 LSNE Contract Manufacturing
11.10.1 LSNE Contract Manufacturing Company Detail
11.10.2 LSNE Contract Manufacturing Business Overview
11.10.3 LSNE Contract Manufacturing Biologics Fill-Finish Services Introduction
11.10.4 LSNE Contract Manufacturing Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.10.5 LSNE Contract Manufacturing Recent Development
11.11 Ajinomoto Bio-Pharma Services
11.11.1 Ajinomoto Bio-Pharma Services Company Detail
11.11.2 Ajinomoto Bio-Pharma Services Business Overview
11.11.3 Ajinomoto Bio-Pharma Services Biologics Fill-Finish Services Introduction
11.11.4 Ajinomoto Bio-Pharma Services Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.11.5 Ajinomoto Bio-Pharma Services Recent Development
11.12 CMIC CMO
11.12.1 CMIC CMO Company Detail
11.12.2 CMIC CMO Business Overview
11.12.3 CMIC CMO Biologics Fill-Finish Services Introduction
11.12.4 CMIC CMO Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.12.5 CMIC CMO Recent Development
11.13 GRAM (Grand River Aseptic Manufacturing)
11.13.1 GRAM (Grand River Aseptic Manufacturing) Company Detail
11.13.2 GRAM (Grand River Aseptic Manufacturing) Business Overview
11.13.3 GRAM (Grand River Aseptic Manufacturing) Biologics Fill-Finish Services Introduction
11.13.4 GRAM (Grand River Aseptic Manufacturing) Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.13.5 GRAM (Grand River Aseptic Manufacturing) Recent Development
11.14 TAIYO Pharma Tech Co.,Ltd.
11.14.1 TAIYO Pharma Tech Co.,Ltd. Company Detail
11.14.2 TAIYO Pharma Tech Co.,Ltd. Business Overview
11.14.3 TAIYO Pharma Tech Co.,Ltd. Biologics Fill-Finish Services Introduction
11.14.4 TAIYO Pharma Tech Co.,Ltd. Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.14.5 TAIYO Pharma Tech Co.,Ltd. Recent Development
11.15 HALIX
11.15.1 HALIX Company Detail
11.15.2 HALIX Business Overview
11.15.3 HALIX Biologics Fill-Finish Services Introduction
11.15.4 HALIX Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.15.5 HALIX Recent Development
11.16 Cognate BioServices
11.16.1 Cognate BioServices Company Detail
11.16.2 Cognate BioServices Business Overview
11.16.3 Cognate BioServices Biologics Fill-Finish Services Introduction
11.16.4 Cognate BioServices Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.16.5 Cognate BioServices Recent Development
11.17 Afton Scientific
11.17.1 Afton Scientific Company Detail
11.17.2 Afton Scientific Business Overview
11.17.3 Afton Scientific Biologics Fill-Finish Services Introduction
11.17.4 Afton Scientific Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.17.5 Afton Scientific Recent Development
11.18 Novasep
11.18.1 Novasep Company Detail
11.18.2 Novasep Business Overview
11.18.3 Novasep Biologics Fill-Finish Services Introduction
11.18.4 Novasep Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.18.5 Novasep Recent Development
11.19 Emergent BioSolutions
11.19.1 Emergent BioSolutions Company Detail
11.19.2 Emergent BioSolutions Business Overview
11.19.3 Emergent BioSolutions Biologics Fill-Finish Services Introduction
11.19.4 Emergent BioSolutions Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.19.5 Emergent BioSolutions Recent Development
11.20 Seikagaku
11.20.1 Seikagaku Company Detail
11.20.2 Seikagaku Business Overview
11.20.3 Seikagaku Biologics Fill-Finish Services Introduction
11.20.4 Seikagaku Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.20.5 Seikagaku Recent Development
11.21 Jiangshu YAOHAI Bio-pharmaceutical
11.21.1 Jiangshu YAOHAI Bio-pharmaceutical Company Detail
11.21.2 Jiangshu YAOHAI Bio-pharmaceutical Business Overview
11.21.3 Jiangshu YAOHAI Bio-pharmaceutical Biologics Fill-Finish Services Introduction
11.21.4 Jiangshu YAOHAI Bio-pharmaceutical Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.21.5 Jiangshu YAOHAI Bio-pharmaceutical Recent Development
11.22 Akron Biotech
11.22.1 Akron Biotech Company Detail
11.22.2 Akron Biotech Business Overview
11.22.3 Akron Biotech Biologics Fill-Finish Services Introduction
11.22.4 Akron Biotech Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.22.5 Akron Biotech Recent Development
11.23 Symbiosis Pharmaceutical Services
11.23.1 Symbiosis Pharmaceutical Services Company Detail
11.23.2 Symbiosis Pharmaceutical Services Business Overview
11.23.3 Symbiosis Pharmaceutical Services Biologics Fill-Finish Services Introduction
11.23.4 Symbiosis Pharmaceutical Services Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.23.5 Symbiosis Pharmaceutical Services Recent Development
11.24 Techdow
11.24.1 Techdow Company Detail
11.24.2 Techdow Business Overview
11.24.3 Techdow Biologics Fill-Finish Services Introduction
11.24.4 Techdow Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.24.5 Techdow Recent Development
11.25 Vigene Biosciences
11.25.1 Vigene Biosciences Company Detail
11.25.2 Vigene Biosciences Business Overview
11.25.3 Vigene Biosciences Biologics Fill-Finish Services Introduction
11.25.4 Vigene Biosciences Revenue in Biologics Fill-Finish Services Business (2018-2023)
11.25.5 Vigene Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing
Ajinomoto Bio-Pharma Services
CMIC CMO
GRAM (Grand River Aseptic Manufacturing)
TAIYO Pharma Tech Co.,Ltd.
HALIX
Cognate BioServices
Afton Scientific
Novasep
Emergent BioSolutions
Seikagaku
Jiangshu YAOHAI Bio-pharmaceutical
Akron Biotech
Symbiosis Pharmaceutical Services
Techdow
Vigene Biosciences
听
听
*If Applicable.
